NUTX
Nutex Health Inc
204.60$
+1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -119.5% | -70.2% | -26.1% | -32.5% | -12.5% | 15.5% | – | – | -1,332.1% | -525.4% | 12.5% | 29.7% | 52.3% | 23.1% | 0.5% | 4.8% | 28.3% | |
| – | 0.3% | 0.1% | 0.2% | 0.5% | 0.5% | 0.4% | – | – | 2.1% | 0.6% | 2.6% | 2.2% | 2.3% | 6.0% | 7.1% | 4.0% | 2.3% | |
| – | 31.5% | 0.5% | 0.0% | – | – | – | – | – | 1,723.0% | 227.7% | 0.5% | 0.9% | 3.1% | 0.1% | 1.1% | 3.5% | 13.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 10.9% | 16.1% | 9.2% | 183.9% | – | – | – | |
| – | 44.3% | -12.3% | -8.2% | 13.0% | -14.5% | 20.7% | – | – | 361.0% | 340.3% | -22.5% | -25.4% | 0.8% | 29.3% | -0.7% | -21.8% | -10.0% | |
| – | 0.0% | 0.4% | 0.8% | 0.5% | 0.0% | 0.2% | – | – | 0.0% | 0.0% | 33.3% | 22.3% | 11.1% | 6.7% | 3.8% | 0.5% | 0.3% | |
| – | 88.8% | -37.7% | 0.7% | 26.2% | 0.1% | -0.4% | – | – | 3.8% | -128.0% | -32.2% | -22.3% | -11.2% | -2.0% | -4.5% | -0.6% | -0.6% | |
| – | – | – | – | – | – | – | – | – | – | – | 19.5% | 21.5% | 43.5% | 23.4% | 2.1% | 1.3% | 8.5% | |
| – | – | – | – | – | – | – | – | – | – | – | -4.2% | 0.0% | – | 2.2% | 0.0% | 0.0% | -0.6% | |
| – | – | – | – | – | – | – | – | – | – | – | 36.6% | 17.0% | -1.0% | -2.5% | 1.1% | -1.5% | -2.2% | |
| – | 1.1% | 1.8% | – | -1.2% | 7.1% | -5.1% | – | – | 1,326.3% | 771.1% | 22.4% | -0.9% | -38.0% | -21.9% | -0.9% | 0.2% | -11.2% | |
| – | 242.5% | -30.9% | -9.4% | -7.5% | -5.3% | 10.0% | – | – | -2.0% | 120.2% | 2.7% | 6.4% | 3.2% | -0.8% | -4.9% | 4.5% | 16.6% | |
| – | -445.4% | -70.7% | -26.8% | -33.0% | -12.5% | 15.3% | – | – | -1,332.1% | -525.4% | -20.8% | 7.3% | 41.2% | 16.4% | -3.3% | 4.3% | 28.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.